WILMINGTON, N.C., Feb. 22 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today the following changes to its executive management team:
CEO and President J. Tobin Geatz said: "We are excited to have these accomplished industry professionals on board to strengthen our leadership team. Having previously helped other innovative companies accelerate their revenues and growth paths, these executives, without doubt, are equipped and ready to guide Inclinix during this time of tremendous growth."
About Inclinix
Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO. Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit www.inclinix.com
CONTACT: Bill Gwinn, +1-910-332-2640, bgwinn@inclinix.com, or Ruth Dobson,
+1-910-332-2045, rdobson@inclinix.com, both of Inclinix, Inc.
Web site: http://www.inclinix.com/
